novo nordisk semaglutide lawsuit Makers of compounded Wegovy, Ozempic threatened by FDA move Novo Nordisk sues Hims &

doi: 10.2337/diab.34.3.S74 128 Dahl-JrgensenK

Instruct patients to contact their physician if cholelithiasis or cholecystitis is suspected for appropriate clinical follow-up [see Warnings and Precautions (5.9)]

Important: coverage decisions for semaglutide brand or generic are specific to type 2 diabetes management

The pill is currently in a phase 3 trial its results will readout next year

Heres how semaglutide works, according to Canadian government sources: Federal priorities: pharmaceuticals and affordability The semaglutide approval coincides with Health Canadas 202627 Departmental Plan, which identifies improving the accessibility, affordability, and timeliness of pharmaceuticals for Canadians as one of the departments key priorities for the coming year